by Richard Daverman, PhD
June 2, 2014 -- In April, the Beijing Institute of Genomics (BIG), China Academy of Sciences, together with its commercial partner Zixin Pharmaceutical Industrial, unveiled a China-developed genomic sequencing machine that takes direct aim at Illumina’s (NSDQ: ILMN) state-of-the-art sequencer. BIG claims their machine offers longer sequencing reads and a 30% lower price tag than Illumina’s machine, but admits their machine’s throughput is lower. More details....
Stock Symbol: (SHE: 002118)
Help employers find you! Check out all the jobs and post your resume.
